Fluorometholone
Brand names: FML
Fluorometholone is a topical corticosteroid eye drop used to treat steroid-responsive ocular surface and anterior segment inflammation.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a glucocorticoid that binds corticosteroid receptors to suppress inflammatory mediators and reduce vascular permeability and leucocyte activity in the eye, with a relatively lower propensity to raise intraocular pressure than some other steroids.
Prescribing in practice
- Even with its comparatively lower pressure-raising tendency, prolonged use can still increase intraocular pressure and promote cataract and may mask or worsen infection, so ophthalmic supervision is needed.
- It is contraindicated in untreated infective eye conditions, including herpes simplex (dendritic) keratitis and most acute purulent infections.
- Prolonged courses should be tapered rather than stopped abruptly.
Monitoring
Monitor intraocular pressure with prolonged use and review for signs of infection or lens changes.
Counselling the patient
- Shake the bottle if instructed and use the drops exactly as prescribed.
- Report any eye pain, reduced vision or worsening redness.
- Attend follow-up so your eye pressure can be checked.
Evidence & guidelines
Topical corticosteroids such as fluorometholone are established for steroid-responsive ocular inflammation, with use guided by the SPC.
Reference: RCOphth guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme